Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 15 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Genitourinary 7 Gynecologic 5 Tumor-Agnostic 1 Thoracic 1 Other solid neoplasm 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Anal Canal Carcinoma 1

Interventions

Blood Specimen Collection 87 Surveys and Questionnaires 80 Surgical Procedures, Operative 54 Observation 44 Drug Therapy 44 Bevacizumab 42 Colonoscopy 41 Biopsy 35 Hepatectomy 33 Capecitabine 27 Neoadjuvant Therapy 26 Immune Checkpoint Inhibitors 26 regorafenib 25 Interviews as Topic 25 Radiotherapy 24 Oxaliplatin 24 Sorafenib 22 Magnetic Resonance Spectroscopy 22 lenvatinib 21 Endoscopic Mucosal Resection 21 Specimen Handling 18 Immunohistochemistry 18 Endoscopy 18 Pancreaticoduodenectomy 17 Liquid Biopsy 17 Gastrectomy 17 Endoscopic Ultrasound-Guided Fine Needle Aspiration 17 Tomography, X-Ray Computed 16 Gastroscopy 16 Fluorouracil 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Brachytherapy × Gastrointestinal × Clear all

NCT03465501 2018-03-14

BOOST-CA

Institut Paoli-Calmettes

Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡